Q2 2023 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to Aurinia Pharmaceuticals Inc. Second Quarter 2023 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, James Harrell, Investor Relations for Aurinia Pharmaceuticals. Thank you. You may begin.
Thank you, operator, and thanks, everyone, for joining today's call and webcast to review and discuss Aurinia's second quarter and 6-month 2023 financial and operational results. Joining me on the call this morning are Peter Greenleaf, Chief Executive Officer; and Joe Miller, our Chief Financial Officer.
This morning, Aurinia issued a press release announcing its financial results and operational highlights for the second quarter and 6 months ended June 30, 2023. In addition, the company filed its quarterly financial statements on Form 10-Q. For more information, please refer to Aurinia's filings with the U.S. Securities and Exchange Commission, which are also available on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |